Press

Arrive Health data illustrates the growing demand for amoxicillin, especially in those aged 0-12 years old.

Arrive Health ranks number 61 on Deloitte Technology Fast 500 list of fastest-growing companies in North America.

New Arrive Health data shows a recent spike in psychiatric medication prescriptions in August, as well as medications for anxiety, depression, and other mental health conditions.

These StartUp Health portfolio companies represent the diverse, impactful, and innovative work being done by our global army of Health Transformers throughout the world of digital health.

Newly published Arrive Health data shows behavioral health prescriptions surged early in the pandemic, leveled off, and began to rise again more recently.

A new study from the AMA shows physicians growing ever more comfortable with health care technology, including in the non-clinical area of price transparency and related data tools.

At the 2022 PBMI Conference, executives from Arrive Health and OptumRx say they have ironed out many of the historical challenges with real-time benefit checks.

An interview with COO Christie Callahan in regards to payer price transparency rules and progress toward true consumer centricity.

Arrive Health ranked #12 for healthcare services companies on this year's Inc 5000 list.

Arrive Health ranked #181 on this year's Inc 5000 list, putting the company in the top 1% of the nation's fastest-growing privately held companies.

A real-time prescription benefit EHR integration is helping providers at Presbyterian Healthcare find treatment options that fit the needs, and wallets, of patients.

COO Christie Callahan discusses her career path, the challenges women in leadership face, and what inspires her to make a difference in healthcare.